Evaluation of rezafungin provisional CLSI clinical breakpoints and epidemiological cutoff values tested against a worldwide collection of contemporaneous invasive fungal isolates (2019 to 2020) by Carvalhaes C, Klauer A, Rhomberg PR, Pfaller MA, Castanheira M in J. Clin. Microbiol. 2022; 60 (4), https://doi.org/10.1128/jcm.02449-21.
JMI LABS IS NOW PART OF LEARN MORE
Get Support From A Premier Microbiology Laboratory